menu search

Nextcure presents non-clinical data defining the mechanism of nc525 at the 2023 federation of clinical immunology societies (focis) annual meeting

BELTSVILLE, Md., June 21, 2023 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering...

June 21, 2023, 8:05 pm

Why is lumiradx (lmdx) stock up 30% today?

LumiraDx (NASDAQ: LMDX ) stock is heading higher on Wednesday morning after the company received approval for its Covid and RSV tests. The U.K.'s ...

June 21, 2023, 8:38 am

Lumiradx receives uk ctda approval for covid ultra and covid & rsv tests

LumiraDx SARS-CoV-2 Ag Ultra & SARS-CoV-2 Ag & RSV tests have been successfully validated by the medicines ...

June 20, 2023, 8:15 pm

Lilly to present new research in the treatment of diabetes and obesity at the american diabetes association's® 83rd scientific sessions

Full SURMOUNT-2 phase 3 data on the efficacy and safety of tirzepatide for chronic weight management in adults with obesity or overweight and type 2 d...

June 20, 2023, 1:37 pm

Bristol myers sues us government over medicare drug price negotiation plan

Bristol Myers Squibb Co on Friday sued the U.S. government in an attempt to halt the Medicare drug price negotiation program that analysts believe wil...

June 16, 2023, 6:02 pm

2 best biotech stocks to buy right now

These European pharma giants have long-established records of success. AstraZeneca has 12 medicines tha...

June 16, 2023, 10:07 am

Patient & provider advocates applaud senate reintroduction of the cancer drug parity act

Bipartisan legislation will bring equality to insurance coverage of life-saving medicines WASHINGTON, J...

June 15, 2023, 11:00 pm

Atossa to participate in fireside chat at healthcare virtual conference presented by maxim group llc

SEATTLE, June 14, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative ...

June 14, 2023, 9:15 am

Atossa therapeutics is looking for a step-change in breast cancer therapy

Breast cancer is the leading cause of cancer death in American women, with around 280,000 women diagnosed annually, so anything that can predict the p...

June 14, 2023, 8:00 am

Novartis stock screams value after chinook therapeutics buyout

That value proposition took a huge step forward on Monday when Novartis announced a $3.2 billion acquisition of Seattle-based biotechnology company Ch...

June 13, 2023, 8:05 am

Chinook therapeutics to present updated data from zigakibart (bion-1301) phase 1/2 trial in patients with iga nephropathy (igan) at the 60th european renal association (era) congress

SEATTLE, June 12, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, developmen...

June 12, 2023, 4:00 pm

Novartis (nvs) to buy chinook for $3.5b to strengthen pipeline

Novartis (NVS) is looking to strengthen its renal pipeline with the acquisition of Chinook Therapeutics for $3.5 billion, which adds two late-stage ...

June 12, 2023, 1:43 pm

Atossa completes enrollment of pharmacokinetic run-in cohort in phase 2 evangeline clinical trial evaluating (z)-endoxifen as a neoadjuvant treatment for er+ / her2- breast cancer

SEATTLE, June 12, 2023 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative...

June 12, 2023, 1:15 pm

Atossa finishes pk run-in cohort enrollment in breast cancer trial

Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cance...

June 12, 2023, 10:52 am

Revolution medicines to participate in upcoming investor conferences

REDWOOD CITY, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing target...

June 8, 2023, 4:05 pm

Michael brush: biotech stocks could soon get a m&a boost. here are 3 likely takeover plays.

Big pharma will be looking to acquire companies with promsing new medicines. Read Full Story The post Michael Brush: Biotech stocks could soon get a M...

June 5, 2023, 7:05 pm

Springworks therapeutics announces pdufa date extension for nirogacestat nda

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review; New PDUFA Date Set to November 27, 2023 STAMFORD, Conn., June 05...

June 5, 2023, 10:30 am

Looking for passive income at a decent price? buy these 2 stocks

High-quality dividend stocks typically aren't cheap. Viatris has a great roster of medicines on the mar...

June 5, 2023, 5:05 am

This biotech could soon go parabolic, but should you buy it?

Blueprint medicines just got a critical green light from regulators for Ayvakit. This treats a rare and...

June 4, 2023, 8:45 am

Praxis precision medicines to present at the 2023 jefferies healthcare conference

BOSTON, June 02, 2023 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating gene...

June 2, 2023, 9:00 am


Search within

Pages Search Results: